Evidence map›Paper›PMID 29421321›Full record

ArticleAntiviral research2018

2017 international meeting of the Global Virus Network.

Mike Catton, Glenda Gray, Diane Griffin, Hideki Hasegawa, Stephen J Kent, Jason Mackenzie, Edward McSweegan, Natalia Mercer, Linfa Wang

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Antiviral research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Factors responsible for the emergence of novel viruses: An emphasis on SARS-CoV-2.Current opinion in environmental science & health · 2022
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 5 countries.

Mike CattonVictorian Infectious Diseases Reference Laboratory, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Glenda GraySouth African Medical Research Council, Cape Town, South Africa.
Diane GriffinDepartment of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, MD, USA.
Hideki HasegawaNational Institute of Infectious Diseases, Tokyo, Japan.
Stephen J KentDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Jason MackenzieDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Edward McSweeganGlobal Virus Network, Baltimore, MD, USA. Electronic address: emcsweegan@gvn.org.
Natalia MercerGlobal Virus Network, Baltimore, MD, USA.
Linfa WangEmerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore.
Global Virus Network · USPeter Doherty Institute · AUDuke-NUS Medical School · SGJohns Hopkins University · USNational Institute of Infectious Diseases · JPSouth African Medical Research Council · ZAVictorian Infectious Diseases Reference Laboratory · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Global Virus Network (GVN) was established in 2011 to strengthen research and responses to emerging viral causes of human disease and to prepare against new viral pandemics. There are now 40 GVN Centers of Excellence and 6 Affiliate laboratories in 24 countries. The 2017 meeting was held from September 25-27 in Melbourne, Australia, and was hosted by the Peter Doherty Institute for Infection and Immunity and the Institut Pasteur. This report highlights the recent accomplishments of GVN researchers in several important areas of medical virology, including the recent Zika epidemic, infections by human papillomavirus, influenza, HIV, hepatitis C, HTLV-1, and chikungunya viruses, and new and emerging viruses in the Australasia region. Plans for the 2018 meeting also are noted.

Indexed as

AustraliaBiomedical ResearchCommunicable Diseases, EmergingGlobal HealthHumansInformation DisseminationInformation ServicesPandemicsVirus DiseasesEmerging virusesGlobal virus networkInternational collaborationsMedical virology

Identifiers

PMID29421321
PMCPMC7113722
OpenAlexW2596177629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.